ConductScience.org, home

Paper11479214

Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.

Oesterreich S and 7 others. Cancer Res, 2001. Cited by 138 papers, by iCite.

Cite this record

ConductScience Library. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Papers, record 11479214. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11479214

Download JSON
Cell line
MCF-7/C4-122 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
PubMed
Journal
Cancer Res
PubMed
Year
2001
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
138
iCite
Relative citation ratio, by iCite
3
iCite
Revised in PubMed
2025-11-04
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Oesterreich SS
2Zhang PP
3Guler RLR L
4Sun XX
5Curran EME M
6Welshons WVW V
7Osborne CKC K
8Lee AVA V

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
EstradiolMajor topic
Insulin-Like Growth Factor IMajor topic
PhosphoproteinsMajor topic
Receptor, IGF Type 1Major topic
Receptors, EstrogenMajor topic
Signal TransductionMajor topic
Cell Division
Cyclin D1
Estrogen Receptor alpha
Hemagglutinins
Humans
Insulin Receptor Substrate Proteins
Phosphorylation
Transfection
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA50354NCI NIH HHSUnited StatesR29CA050354PubMed and NIHNIH RePORTER
P50 CA58183NCI NIH HHSUnited StatesP50CA058183PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by55

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.

PMIDTitleJournalYearIn PapersSource
39207954ESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and Phenotypes.Endocrinology2024https://conductscience.org/library/papers/39207954PubMed
37808197Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future.Front Pharmacol2023https://conductscience.org/library/papers/37808197PubMed
35784325Is Estrogen a Missing Culprit in Thyroid Eye Disease? Sex Steroid Hormone Homeostasis Is Key to Other Fibrogenic Autoimmune Diseases - Why Not This One?Front Immunol2022https://conductscience.org/library/papers/35784325PubMed
34373577RAC1 plays an essential role in estrogen receptor alpha function in breast cancer cells.Oncogene2021https://conductscience.org/library/papers/34373577PubMed
33405908A Gene Expression Biomarker Identifies Chemical Modulators of Estrogen Receptor α in an MCF-7 Microarray Compendium.Chem Res Toxicol2021https://conductscience.org/library/papers/33405908PubMed
30229539Insulin Receptor Substrate Suppression by the Tyrphostin NT157 Inhibits Responses to Insulin-Like Growth Factor-I and Insulin in Breast Cancer Cells.Horm Cancer2018https://conductscience.org/library/papers/30229539PubMed
30132047Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation.Arch Toxicol2018https://conductscience.org/library/papers/30132047PubMed
29963233ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer.Oncotarget2018https://conductscience.org/library/papers/29963233PubMed
29692855Exploring the Pharmacological Mechanism of Danzhi Xiaoyao Powder on ER-Positive Breast Cancer by a Network Pharmacology Approach.Evid Based Complement Alternat Med2018https://conductscience.org/library/papers/29692855PubMed
27527851Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells.Oncotarget2016https://conductscience.org/library/papers/27527851PubMed
27446805Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways.Front Oncol2016https://conductscience.org/library/papers/27446805PubMed
27444280The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies.Tumour Biol2016https://conductscience.org/library/papers/27444280PubMed
27009360Dynamin II is required for 17β-estradiol signaling and autophagy-based ERα degradation.Sci Rep2016https://conductscience.org/library/papers/27009360PubMed
26113056A Role for Histone H2B Variants in Endocrine-Resistant Breast Cancer.Horm Cancer2015https://conductscience.org/library/papers/26113056PubMed
25674003The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.Onco Targets Ther2015https://conductscience.org/library/papers/25674003PubMed
24716121Genistein as a Potential Anticancer Agent against Ovarian Cancer.J Tradit Complement Med2012https://conductscience.org/library/papers/24716121PubMed
24670685Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer.Sci Transl Med2014https://conductscience.org/library/papers/24670685PubMed
24601643Histone H1 phosphorylation in breast cancer.J Proteome Res2014https://conductscience.org/library/papers/24601643PubMed
24281069RETRACTED: Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells.Cancers (Basel)2010https://conductscience.org/library/papers/24281069PubMed
24119434Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies.BMC Cancer2013https://conductscience.org/library/papers/24119434PubMed

See all 55 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11479214

GET https://conductscience.org/api/papers/v1/11479214/cited_by?page=2